AU558445B2 - 1:-ethoxycarbonyloxyethyl ester of valproic acid - Google Patents

1:-ethoxycarbonyloxyethyl ester of valproic acid

Info

Publication number
AU558445B2
AU558445B2 AU21421/83A AU2142183A AU558445B2 AU 558445 B2 AU558445 B2 AU 558445B2 AU 21421/83 A AU21421/83 A AU 21421/83A AU 2142183 A AU2142183 A AU 2142183A AU 558445 B2 AU558445 B2 AU 558445B2
Authority
AU
Australia
Prior art keywords
valproic acid
ethoxycarbonyloxyethyl ester
ester
acid
ethoxycarbonyloxyethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU21421/83A
Other languages
English (en)
Other versions
AU2142183A (en
Inventor
David Ladkani
Ben Zion Weiner
Haim Yellin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceutical Industries Ltd
Original Assignee
Teva Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd filed Critical Teva Pharmaceutical Industries Ltd
Publication of AU2142183A publication Critical patent/AU2142183A/en
Application granted granted Critical
Publication of AU558445B2 publication Critical patent/AU558445B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C68/00—Preparation of esters of carbonic or haloformic acids
    • C07C68/06—Preparation of esters of carbonic or haloformic acids from organic carbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/96—Esters of carbonic or haloformic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
AU21421/83A 1983-01-05 1983-11-16 1:-ethoxycarbonyloxyethyl ester of valproic acid Ceased AU558445B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL67623A IL67623A (en) 1983-01-05 1983-01-05 1'-ethoxycarbonyloxyethyl ester of valproic acid,its preparation and pharmaceutical compositions containing it
IL67623 1983-01-05

Publications (2)

Publication Number Publication Date
AU2142183A AU2142183A (en) 1984-07-12
AU558445B2 true AU558445B2 (en) 1987-01-29

Family

ID=11053985

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21421/83A Ceased AU558445B2 (en) 1983-01-05 1983-11-16 1:-ethoxycarbonyloxyethyl ester of valproic acid

Country Status (9)

Country Link
US (1) US4595695A (enExample)
EP (1) EP0114720B1 (enExample)
JP (1) JPS59128359A (enExample)
AT (1) ATE18197T1 (enExample)
AU (1) AU558445B2 (enExample)
CA (1) CA1284152C (enExample)
DE (1) DE3460035D1 (enExample)
IL (1) IL67623A (enExample)
ZA (1) ZA838666B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL67623A (en) * 1983-01-05 1984-09-30 Teva Pharma 1'-ethoxycarbonyloxyethyl ester of valproic acid,its preparation and pharmaceutical compositions containing it
IT1190133B (it) * 1986-06-19 1988-02-10 Chiesi Farma Spa Derivati di acido valproico e di acido (e)-2-valproenoico,procedimento per la loro preparazione e relative composizioni farmaceutiche
CN1649600A (zh) 2002-02-28 2005-08-03 A&D生物科学公司 氟西汀及类似物的糖醛酰胺、苷和原酸酯苷及其应用
US20050107310A1 (en) * 2002-03-19 2005-05-19 Holick Michael F. Carboxylic acid glycuronides, glycosamides and glycosides of quinolones, penicillins, analogs, and uses thereof
US20050255038A1 (en) * 2002-04-12 2005-11-17 A And D Bioscience, Inc. Conjugates comprising cancer cell specific ligands, a sugar and diagnostic agents and uses thereof
CA2484891A1 (en) * 2002-05-07 2003-11-20 A & D Bioscience, Inc. Conjugates comprising central nervous system active drug
US20050215487A1 (en) * 2002-06-27 2005-09-29 Holick Michael F Conjugates comprising an nsaid and a sugar and uses thereof
EP1567674A4 (en) * 2002-11-22 2007-09-26 Univ Johns Hopkins AIM FOR THE THERAPY OF COGNITIVE IMMUNITY
WO2007028030A2 (en) * 2005-09-02 2007-03-08 Picobella, Llc Oncogenic regulatory rnas for diagnostics and therapeutics
US7459280B2 (en) * 2006-02-27 2008-12-02 Picobella, Llc Methods for diagnosing and treating kidney cancer
US7763650B2 (en) * 2006-03-15 2010-07-27 Medipharma S.A. Pharmaceutical compound and method
US20080267977A1 (en) * 2007-04-26 2008-10-30 Friedrich-Alexander University Of Erlangen-Nuremberg Combined immunological agent and sensitizing agent for the treatment of cancer
BRPI0920342A2 (pt) 2008-10-16 2020-06-23 The Johns Hopkins University Uso de um inibidor da proteína vesicular sináptica 2a (sv2a) ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica para melhora da função cognitiva, uso de levitiracetam ou um sal farmaceuticamente aceitável do mesmo, uso de brivaracetam ou um sal farmaceuticamente aceitável do mesmo, uso do seletracetam ou um sal farmaceuticamente aceitável do mesmo
CN109662964A (zh) * 2010-02-09 2019-04-23 约翰斯.霍普金斯大学 用于改善认知功能的方法和组合物
SG11201407310TA (en) * 2012-05-08 2014-12-30 Cellix Bio Private Ltd Compositions and methods for the treatment of neurological disorders
EP3610890A1 (en) 2012-11-14 2020-02-19 The Johns Hopkins University Methods and compositions for treating schizophrenia
CN105142623A (zh) 2013-03-15 2015-12-09 艾吉因生物股份有限公司 用于改善认知功能的方法和组合物
EP2968237A4 (en) 2013-03-15 2016-08-31 Univ Johns Hopkins METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
JP6899043B2 (ja) 2015-05-22 2021-07-07 エージンバイオ， インコーポレイテッド レベチラセタムの持続放出性医薬組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2442M (fr) * 1962-10-17 1964-04-06 Henry Eugene L'acide dipropylacétique et ses dérivés en tant que nouveuax médicaments dépresseurs du systeme nerveux central.
US3646201A (en) * 1969-07-31 1972-02-29 Liggett & Myers Inc Salicylate carbonate compounds
GB1598568A (en) * 1977-04-19 1981-09-23 Glaxo Lab Ltd Esters of(6r,7r)-3-carbamoyloxymethyl-7-((z)-2-(fur-2-yl)-2-methoxyiminoacetamido)-ceph-3-em-4-carboxylic acid
DE3262698D1 (en) * 1981-11-17 1985-04-25 Kabivitrum Ab Antifibrinolytically active compounds
US4542158A (en) * 1981-12-21 1985-09-17 Merck & Co., Inc. Prodrug esters of diflunisal and related compounds
NZ202721A (en) * 1981-12-21 1985-12-13 Merck & Co Inc Diflunisal derivatives and pharmaceutical compositions
US4426391A (en) * 1982-09-15 1984-01-17 Merck & Co., Inc. [(Alkoxycarbonyl)oxy]alkyl esters of methyldopa
IL67445A (en) * 1982-12-09 1985-11-29 Teva Pharma Ethoxycarbonyloxy ethyl esters of non-steroidal anti-inflammatory carboxylic acids
IL67623A (en) * 1983-01-05 1984-09-30 Teva Pharma 1'-ethoxycarbonyloxyethyl ester of valproic acid,its preparation and pharmaceutical compositions containing it

Also Published As

Publication number Publication date
IL67623A0 (en) 1983-05-15
EP0114720A1 (en) 1984-08-01
JPS6229423B2 (enExample) 1987-06-25
EP0114720B1 (en) 1986-02-26
DE3460035D1 (en) 1986-04-03
AU2142183A (en) 1984-07-12
ATE18197T1 (de) 1986-03-15
US4595695A (en) 1986-06-17
JPS59128359A (ja) 1984-07-24
ZA838666B (en) 1984-07-25
CA1284152C (en) 1991-05-14
IL67623A (en) 1984-09-30

Similar Documents

Publication Publication Date Title
AU558445B2 (en) 1:-ethoxycarbonyloxyethyl ester of valproic acid
IL72381A0 (en) Pharmaceutical composition based on valproic acid
AU553087B2 (en) Curable polycarboxylic acid composition
AU554354B2 (en) Phenoxyalkyl carboxylic acid derivatives
AU533471B2 (en) Pharmaceutical composition comprising modified polyriboinosinic-polyribocytidylic acid
AU8419482A (en) Cyanacrylic acid ester based adhesives
AU553874B2 (en) Thiazaspirane derivatives
AU7457887A (en) Tetrahydrobenzothiazoles
IE792328L (en) Derivatives of dihydropyrrole and tetrahydropyridine.
DE3265503D1 (en) Bis-esters of alkanediols, pharmaceutical compositions thereof and intermediates therefor
ES483087A1 (es) Procedimiento para la obtencion de bencimidazolcarbamatos
NO158684C (no) Fremgangsmaate for fremstilling av propionsyre fra fermentert myse.
AU525916B2 (en) 3-chlorostyryl-2,2,-dimethyl-cyclopropane carboxylic acid esters
AU4668179A (en) N,n-dimethyl-0-pyrazolyl-carbamic acid esters
EP0490224A3 (de) Salicylaldehyd- und Salicylsäurederivate sowie deren Schwefelanaloge, Verfahren und Zwischenprodukte zu ihrer Herstellung
AU557394B2 (en) L-arginine isoxicamate
AU575067B2 (en) Salts of l or (s)-3-(3,4-dihydroxyphenyl)-2- methylalanine esters
ES8206510A1 (es) Procedimiento para la preparacion del compuesto 3-metil-3- (o-metoxi-fenoxi)-benzo-2,4-dioxaciclohexanona
EP0338493A3 (de) Tetrahydro-4-phenylimino-3-thiophenessigsäuren
EP0338494A3 (de) 3-Anilino-2-hydroxycarbonyl-4-thiophenessigsäuren
JPS5246066A (en) Preparation of optically active 5-oxo-2-pyrrolipinyl acetic acid salts
AU528676B2 (en) 3,7-disubstituted-3-cephem-4-carboxylic acid compounds
ES8608534A1 (es) Procedimiento para la fabricacion de etoposido.
JPS5295630A (en) Propionic acid and pyruvic acid derivatives
FI885277L (fi) 2,4-diklor-5-fluorbenzoyl -aettikssyraetylester.